Mechanisms of constipation in older persons and effects of fiber compared with placebo - PubMed (original) (raw)
Clinical Trial
Mechanisms of constipation in older persons and effects of fiber compared with placebo
L J Cheskin et al. J Am Geriatr Soc. 1995 Jun.
Abstract
Objective: To investigate the mechanisms of constipation and the effect of fiber supplementation on physiology, mechanisms, stool parameters, and colonic transit times in a group of constipated older patients.
Design: Single-blind, randomized, placebo-controlled fiber intervention with crossover.
Setting: A university-based outpatient center.
Patients: Ten community-living older men and women, healthy except for chronic constipation.
Interventions: Patients were given either 24 g psyllium fiber or placebo fiber daily for 1 month, then crossed over to the other arm for an additional month. Structured testing, including total gut transit time and rectal and colonic manometry, was performed at the end of each intervention month. Patients recorded stool frequency, consistency, and weights daily.
Results: The predominant mechanism for constipation in these patients was outlet delay caused by pelvic dyssynergia. Fiber decreased total gut transit time from 53.9 hours (placebo condition) to 30.0 hours (P < .05). Stool weights and consistency were not significantly improved by fiber, though there was a trend toward an increase in stool frequency (1.3 vs 0.8 bowel movements per day.) Pelvic floor dyssynergia was not remedied by fiber, even when constipation was clinically improved.
Conclusions: Fiber supplementation appeared to benefit constipated older patients clinically, and it improved colonic transit time, but it did not rectify the most frequent underlying abnormality, pelvic floor dyssynergia.
Similar articles
- Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation.
Ashraf W, Park F, Lof J, Quigley EM. Ashraf W, et al. Aliment Pharmacol Ther. 1995 Dec;9(6):639-47. doi: 10.1111/j.1365-2036.1995.tb00433.x. Aliment Pharmacol Ther. 1995. PMID: 8824651 Clinical Trial. - Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging.
Major G, Murray K, Singh G, Nowak A, Hoad CL, Marciani L, Silos-Santiago A, Kurtz CB, Johnston JM, Gowland P, Spiller R. Major G, et al. Neurogastroenterol Motil. 2018 Sep;30(9):e13400. doi: 10.1111/nmo.13400. Epub 2018 Jul 30. Neurogastroenterol Motil. 2018. PMID: 30062794 Clinical Trial. - Parameters of anorectal and colonic motility in health and in severe constipation.
Pezim ME, Pemberton JH, Levin KE, Litchy WJ, Phillips SF. Pezim ME, et al. Dis Colon Rectum. 1993 May;36(5):484-91. doi: 10.1007/BF02050015. Dis Colon Rectum. 1993. PMID: 8482168 - Laxative effects of wheat bran and psyllium: Resolving enduring misconceptions about fiber in treatment guidelines for chronic idiopathic constipation.
McRorie JW Jr, Fahey GC Jr, Gibb RD, Chey WD. McRorie JW Jr, et al. J Am Assoc Nurse Pract. 2020 Jan;32(1):15-23. doi: 10.1097/JXX.0000000000000346. J Am Assoc Nurse Pract. 2020. PMID: 31764399 Review. - [The Latin-American Consensus on Chronic Constipation].
Schmulson Wasserman M, Francisconi C, Olden K, Aguilar Paíz L, Bustos-Fernández L, Cohen H, Passos MC, González-Martínez MA, Iade B, Iantorno G, Ledesma Ginatta C, López-Colombo A, Pérez CL, Madrid-Silva AM, Quilici F, Quintero Samudio I, Rodríguez Varón A, Suazo J, Valenzuela J, Zolezzi A. Schmulson Wasserman M, et al. Gastroenterol Hepatol. 2008 Feb;31(2):59-74. doi: 10.1157/13116072. Gastroenterol Hepatol. 2008. PMID: 18279643 Spanish.
Cited by
- Pharmacological basis for the medicinal use of psyllium husk (Ispaghula) in constipation and diarrhea.
Mehmood MH, Aziz N, Ghayur MN, Gilani AH. Mehmood MH, et al. Dig Dis Sci. 2011 May;56(5):1460-71. doi: 10.1007/s10620-010-1466-0. Epub 2010 Nov 17. Dig Dis Sci. 2011. PMID: 21082352 - Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents.
Tse Y, Armstrong D, Andrews CN, Bitton A, Bressler B, Marshall J, Liu LW. Tse Y, et al. Can J Gastroenterol Hepatol. 2017;2017:8612189. doi: 10.1155/2017/8612189. Epub 2017 Feb 8. Can J Gastroenterol Hepatol. 2017. PMID: 28271055 Free PMC article. - Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition.
Shin JE, Jung HK, Lee TH, Jo Y, Lee H, Song KH, Hong SN, Lim HC, Lee SJ, Chung SS, Lee JS, Rhee PL, Lee KJ, Choi SC, Shin ES; Clinical Management Guideline Group under the Korean Society of Neurogastroenterology and Motility. Shin JE, et al. J Neurogastroenterol Motil. 2016 Jul 30;22(3):383-411. doi: 10.5056/jnm15185. J Neurogastroenterol Motil. 2016. PMID: 27226437 Free PMC article. Review. - Chronic constipation: current treatment options.
Liu LW. Liu LW. Can J Gastroenterol. 2011 Oct;25 Suppl B(Suppl B):22B-28B. Can J Gastroenterol. 2011. PMID: 22114754 Free PMC article. Review. - Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.
Paré P, Bridges R, Champion MC, Ganguli SC, Gray JR, Irvine EJ, Plourde V, Poitras P, Turnbull GK, Moayyedi P, Flook N, Collins SM. Paré P, et al. Can J Gastroenterol. 2007 Apr;21 Suppl B(Suppl B):3B-22B. Can J Gastroenterol. 2007. PMID: 17464377 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical